A detailed history of Westside Investment Management, Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Westside Investment Management, Inc. holds 165,944 shares of HROW stock, worth $5.82 Million. This represents 1.59% of its overall portfolio holdings.

Number of Shares
165,944
Previous 209,944 20.96%
Holding current value
$5.82 Million
Previous $4.39 Billion 69.88%
% of portfolio
1.59%
Previous 1.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

SELL
$20.85 - $46.47 $917,400 - $2.04 Million
-44,000 Reduced 20.96%
165,944 $7.45 Billion
Q2 2024

Jul 17, 2024

SELL
$10.0 - $21.64 $16,350 - $35,381
-1,635 Reduced 0.77%
209,944 $4.39 Billion
Q1 2024

Apr 19, 2024

SELL
$9.3 - $13.23 $6,835 - $9,724
-735 Reduced 0.35%
211,579 $2.8 Billion
Q4 2023

Jan 12, 2024

BUY
$8.1 - $16.36 $431,689 - $871,906
53,295 Added 33.51%
212,314 $2.38 Billion
Q3 2023

Nov 15, 2023

BUY
$14.03 - $22.08 $354,608 - $558,072
25,275 Added 18.9%
159,019 $2.29 Billion
Q2 2023

Jul 14, 2023

SELL
$17.37 - $28.08 $292,945 - $473,569
-16,865 Reduced 11.2%
133,744 $2.55 Billion
Q1 2023

May 17, 2023

SELL
$13.84 - $21.46 $542,943 - $841,875
-39,230 Reduced 20.66%
150,609 $3.19 Billion
Q4 2022

Jan 31, 2023

SELL
$10.28 - $14.78 $91,749 - $131,911
-8,925 Reduced 4.49%
189,839 $2.8 Million
Q3 2022

Nov 09, 2022

BUY
$6.57 - $24.88 $7,227 - $27,368
1,100 Added 0.56%
198,764 $2.4 Million
Q2 2022

Jul 15, 2022

BUY
$5.75 - $7.74 $115,828 - $155,914
20,144 Added 11.35%
197,664 $1.44 Million
Q1 2022

Apr 25, 2022

BUY
$6.77 - $8.66 $158,688 - $202,990
23,440 Added 15.21%
177,520 $1.21 Million
Q4 2021

Feb 15, 2022

SELL
$8.5 - $12.0 $6,970 - $9,840
-820 Reduced 0.53%
154,080 $1.33 Million
Q3 2021

Oct 27, 2021

BUY
$6.99 - $10.6 $250,766 - $380,275
35,875 Added 30.14%
154,900 $1.41 Million
Q2 2021

Jul 28, 2021

BUY
$6.68 - $11.07 $282,230 - $467,707
42,250 Added 55.03%
119,025 $1.11 Million
Q1 2021

Apr 14, 2021

BUY
$6.26 - $11.03 $34,117 - $60,113
5,450 Added 7.64%
76,775 $518,000
Q4 2020

Jan 15, 2021

BUY
$4.76 - $6.93 $43,673 - $63,582
9,175 Added 14.76%
71,325 $489,000
Q2 2020

Jul 21, 2020

BUY
$3.61 - $6.47 $5,415 - $9,705
1,500 Added 2.47%
62,150 $323,000
Q1 2020

Apr 16, 2020

BUY
$3.5 - $7.31 $131,950 - $275,587
37,700 Added 164.27%
60,650 $231,000
Q2 2019

Jul 24, 2019

BUY
$4.2 - $8.7 $96,390 - $199,664
22,950 New
22,950 $199,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $950M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Westside Investment Management, Inc. Portfolio

Follow Westside Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westside Investment Management, Inc. with notifications on news.